%20CO.%2C%20LTD/other/BEIJING_CENTERGATE_TECHNOLOGIES_yTdaXkc.png)
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD — Investor Relations & Filings
Beijing Centergate Technologies (Holding) Co., Ltd. focuses on the research, development, production, and distribution of medical and healthcare products. The company’s core operations involve the manufacturing of chemical pharmaceuticals, traditional Chinese medicines, and health supplements. Its product portfolio addresses various therapeutic areas, including cardiovascular health, digestive system treatments, and anti-infective therapies. Additionally, the company provides healthcare services and develops medical devices. Through its specialized subsidiaries, it maintains integrated research and manufacturing capabilities aimed at providing clinical solutions and health management products. The organization emphasizes technological advancement and quality control across its supply chain to meet diverse patient needs and healthcare standards.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 《房地产抵押估价报告》【黑世华房估字【2025】J002号】 | 2025-01-23 | Chinese | |
| 第九届董事会第一次会议决议公告 | 2025-01-23 | Chinese | |
| 关于董事会、监事会完成换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-01-23 | Chinese | |
| 关于公司为多多药业向哈尔滨银行申请5,000万元融资授信提供担保和反担保的公告 | 2025-01-23 | Chinese | |
| 关于召开2025年第二次临时股东会的通知 | 2025-01-23 | Chinese | |
| 关于下属公司为多多药业向佳木斯农信社申请2,000万元融资授信提供担保的公告 | 2025-01-23 | Chinese |
Browse filings by year
27 years- 2026 5 filings
- 2025 36 filings
- 2024 147 filings
- 2023 184 filings
- 2022 182 filings
- 2021 130 filings
- 2020 169 filings
- 2019 183 filings
- 2018 198 filings
- 2017 148 filings
- 2016 180 filings
- 2015 209 filings
- 2014 197 filings
- 2013 109 filings
- 2012 133 filings
- 2011 115 filings
- 2010 111 filings
- 2009 86 filings
- 2008 84 filings
- 2007 135 filings
- 2006 91 filings
- 2005 55 filings
- 2004 40 filings
- 2003 37 filings
- 2002 27 filings
- 2001 5 filings
- 1999 3 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44238372 | 《房地产抵押估价报告》【黑世华房估字【2025】J002号】 | 2025-01-23 | Chinese | ||
| 44238336 | 第九届董事会第一次会议决议公告 | 2025-01-23 | Chinese | ||
| 44238320 | 关于董事会、监事会完成换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-01-23 | Chinese | ||
| 44238299 | 关于公司为多多药业向哈尔滨银行申请5,000万元融资授信提供担保和反担保的公告 | 2025-01-23 | Chinese | ||
| 44238258 | 关于召开2025年第二次临时股东会的通知 | 2025-01-23 | Chinese | ||
| 44238231 | 关于下属公司为多多药业向佳木斯农信社申请2,000万元融资授信提供担保的公告 | 2025-01-23 | Chinese | ||
| 44238212 | 《房地产抵押估价报告》【北京首佳(2025)估字第 FC20250102049号】 | 2025-01-23 | Chinese | ||
| 44238044 | 第九届监事会第一次会议决议公告 | 2025-01-23 | Chinese | ||
| 44238033 | 北京海润天睿律师事务所关于北京中关村科技发展(控股)股份有限公司2025年第一次临时股东会之法律意见书 | 2025-01-23 | Chinese | ||
| 44237966 | 《房地产抵押估价报告》【黑世华房估字【2025】J001号】 | 2025-01-23 | Chinese | ||
| 44237936 | 2025年第一次临时股东会决议公告 | 2025-01-23 | Chinese | ||
| 44237921 | 关于下属公司北京华素盐酸曲马多片一致性评价申报收到国家药品监督管理局《受理通知书》的公告 | 2025-01-13 | Chinese | ||
| 44237907 | 国都证券关于中关村股权分置改革2024年度保荐工作报告书 | 2025-01-09 | Chinese | ||
| 44237843 | 独立董事候选人关于参加独立董事培训并取得独立董事资格证书的承诺函(夏琴) | 2025-01-07 | Chinese | ||
| 44237829 | 独立董事候选人声明与承诺(夏琴) | 2025-01-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53909/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53909 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53909 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53909 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53909}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD (id: 53909)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.